Patients with COVID-19 may complicate their evolution with thromboembolic events.
Incidence of thromboembolic complications are high and also, patients with the critically-ill …

Infection of the lungs with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
via the angiotensin I converting enzyme 2 (ACE2) receptor induces a type of systemic …

Preexisting cardiovascular disease (CVD) is a pivotal risk factor for severe coronavirus
disease 2019 (COVID-19). We investigated the longitudinal (over 1 year and 9 months) …

Severe COVID-19 infections are at high risk of causing thromboembolic events (TEEs).
However, the usual exams may be unavailable or unreliable in predicting the risk of TEEs at …

Background: To date, there are no large-scale data on the association between D-dimer
levels at admission and the occurrence of venous thromboembolism (VTE) in Japanese …

Objective Hypercoagulability and thrombotic complications seen in patients with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the associated …

Abstract Coronavirus Disease 2019 (COVID-19) has been associated with a high
thromboembolic risk among patients in intensive care units. Asian populations may share a …

Abstract Introduction: Coronavirus disease 2019 (COVID-19) infection was declared a
pandemic, causing high mortality and morbidity worldwide. It predisposes patients to both …

Abstract Coronavirus disease 2019 (COVID-19) has become a major health problem
worldwide since 2020. Although the main pathophysiology of COVID-19 is a respiratory …

Abstract Since March 2020, the Coronavirus Disease 2019 (COVID-19) pandemic has
engulfed the world, including Indonesia, for nearly two years. SARS-CoV-2 has undergone …